Page Content
#ffffff
Video
Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Featured
Off
Thumbnail
Schedule Date & Time
Speciality
Currency
Sub Speciality
Sub Sub Speciality
Short Description
Speaker Name: Dr. Daniel Drucker, Senior Scientist, Lunenfeld Tanenbaum Research Institute, Toronto, Canada.
Explore this expert session to:
- Get familiar with the evolution of GLP-1-based therapy beyond glycemic management.
- Understand the clinical role of oral semaglutide and its comparison with injectable semaglutide.
- Review major data from the LEADER, SOUL, and SELECT trials.
- Learn about emerging evidence from the FLOW trial and studies in HFpEF and CKD.
- Explore mechanisms of benefit beyond glucose and body weight reduction.
- Gain insight into future therapies, including tirzepatide and multi-receptor agents.
User Segments
Release Date
Timezone
Featured Order
0
Is Paid
0
Most watched content
Off